Fig. 1From: The efficacy and safety of specific therapies for cardiac Transthyretin-mediated amyloidosis: a systematic review and meta-analysis of randomized trialsPRISMA Flow Diagram. PRISMA flow diagram of study screening and selectionBack to article page
